These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15527257)

  • 21. Structure-based design of novel HIV protease inhibitors: sulfonamide-containing 4-hydroxycoumarins and 4-hydroxy-2-pyrones as potent non-peptidic inhibitors.
    Thaisrivongs S; Janakiraman MN; Chong KT; Tomich PK; Dolak LA; Turner SR; Strohbach JW; Lynn JC; Horng MM; Hinshaw RR; Watenpaugh KD
    J Med Chem; 1996 Jun; 39(12):2400-10. PubMed ID: 8691434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and antiviral activity of P1' arylsulfonamide azacyclic urea HIV protease inhibitors.
    Huang PP; Randolph JT; Klein LL; Vasavanonda S; Dekhtyar T; Stoll VS; Kempf DJ
    Bioorg Med Chem Lett; 2004 Aug; 14(15):4075-8. PubMed ID: 15225729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oximinoarylsulfonamides as potent HIV protease inhibitors.
    Yeung CM; Klein LL; Flentge CA; Randolph JT; Zhao C; Sun M; Dekhtyar T; Stoll VS; Kempf DJ
    Bioorg Med Chem Lett; 2005 May; 15(9):2275-8. PubMed ID: 15837308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New approaches to the industrial synthesis of HIV protease inhibitors.
    Honda Y; Katayama S; Kojima M; Suzuki T; Kishibata N; Izawa K
    Org Biomol Chem; 2004 Jul; 2(14):2061-70. PubMed ID: 15254634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiviral activity of UIC-PI, a novel inhibitor of the human immunodeficiency virus type 1 protease.
    Ghosh AK; Pretzer E; Cho H; Hussain KA; Düzgüneş N
    Antiviral Res; 2002 Apr; 54(1):29-36. PubMed ID: 11888655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction of peptide character of HIV protease inhibitors that exhibit nanomolar potency against multidrug resistant HIV-1 strains.
    Tamamura H; Koh Y; Ueda S; Sasaki Y; Yamasaki T; Aoki M; Maeda K; Watai Y; Arikuni H; Otaka A; Mitsuya H; Fujii N
    J Med Chem; 2003 Apr; 46(9):1764-8. PubMed ID: 12699395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and synthesis of novel HIV-1 protease inhibitors incorporating oxyindoles as the P2'-ligands.
    Ghosh AK; Schiltz G; Perali RS; Leshchenko S; Kay S; Walters DE; Koh Y; Maeda K; Mitsuya H
    Bioorg Med Chem Lett; 2006 Apr; 16(7):1869-73. PubMed ID: 16480871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bis-tetrahydrofuran: a privileged ligand for darunavir and a new generation of hiv protease inhibitors that combat drug resistance.
    Ghosh AK; Ramu Sridhar P; Kumaragurubaran N; Koh Y; Weber IT; Mitsuya H
    ChemMedChem; 2006 Sep; 1(9):939-50. PubMed ID: 16927344
    [No Abstract]   [Full Text] [Related]  

  • 29. Stereoselective synthesis of 3-aminoindan-1-ones and subsequent incorporation into HIV-1 protease inhibitors.
    Arefalk A; Wannberg J; Larhed M; Hallberg A
    J Org Chem; 2006 Feb; 71(3):1265-8. PubMed ID: 16438552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and biological evaluation of novel amprenavir-based P1-substituted bi-aryl derivatives as ultra-potent HIV-1 protease inhibitors.
    Yan J; Huang N; Li S; Yang LM; Xing W; Zheng YT; Hu Y
    Bioorg Med Chem Lett; 2012 Mar; 22(5):1976-9. PubMed ID: 22306123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 3-Tetrahydrofuran and pyran urethanes as high-affinity P2-ligands for HIV-1 protease inhibitors.
    Ghosh AK; Thompson WJ; McKee SP; Duong TT; Lyle TA; Chen JC; Darke PL; Zugay JA; Emini EA; Schleif WA
    J Med Chem; 1993 Jan; 36(2):292-4. PubMed ID: 8423600
    [No Abstract]   [Full Text] [Related]  

  • 32. A Stereoselective Anti-Aldol Route to (3
    Ghosh AK; Li J; Perali RS
    Synthesis (Stuttg); 2006 Sep; 2006(18):3015-3018. PubMed ID: 30443083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lysine sulfonamides as novel HIV-protease inhibitors: Nepsilon-disubstituted ureas.
    Stranix BR; Sauvé G; Bouzide A; Coté A; Sévigny G; Yelle J; Perron V
    Bioorg Med Chem Lett; 2004 Aug; 14(15):3971-4. PubMed ID: 15225709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concise entry to chiral 5-(4-hydroxybutyl)-2(5H)-furanone via HTIB-mediated novel oxidative fragmentation: formal total synthesis of (+)-dubiusamine A.
    Kawasumi M; Iwabuchi Y
    Org Lett; 2013 Apr; 15(7):1788-90. PubMed ID: 23530716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pd(II)-catalyzed cascade reaction with 1,3-chirality transfer; stereoselective synthesis of chiral nonracemic 2,2'-THF-THF ring units.
    Uenishi J; Fujikura Y; Kawai N
    Org Lett; 2011 May; 13(9):2350-3. PubMed ID: 21456592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting the open-flap conformation of HIV-1 protease with pyrrolidine-based inhibitors.
    Böttcher J; Blum A; Dörr S; Heine A; Diederich WE; Klebe G
    ChemMedChem; 2008 Sep; 3(9):1337-44. PubMed ID: 18720485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of alpha,beta-unsaturated 4,5-disubstituted gamma-lactones via ring-closing metathesis catalyzed by the first-generation Grubbs' catalyst.
    Bassetti M; D'Annibale A; Fanfoni A; Minissi F
    Org Lett; 2005 Apr; 7(9):1805-8. PubMed ID: 15844911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short synthesis of the seed germination inhibitor 3,4,5-trimethyl-2(5H)-furanone.
    Surmont R; Verniest G; De Kimpe N
    J Org Chem; 2010 Aug; 75(16):5750-3. PubMed ID: 20704450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and antiviral activities of novel N-alkoxy-arylsulfonamide-based HIV protease inhibitors.
    Sherrill RG; Furfine ES; Hazen RJ; Miller JF; Reynolds DJ; Sammond DM; Spaltenstein A; Wheelan P; Wright LL
    Bioorg Med Chem Lett; 2005 Aug; 15(15):3560-4. PubMed ID: 15975788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conformational analysis of TMC114, a novel HIV-1 protease inhibitor.
    Nivesanond K; Peeters A; Lamoen D; Van Alsenoy C
    J Chem Inf Model; 2008 Jan; 48(1):99-108. PubMed ID: 18173253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.